AAAAAA

   
Results: 1-9 |
Results: 9
DNA-SEQUENCE SELECTIVITY OF TOPOISOMERASES AND TOPOISOMERASE POISONS
Authors: CAPRANICO G BINASCHI M
Citation: G. Capranico et M. Binaschi, DNA-SEQUENCE SELECTIVITY OF TOPOISOMERASES AND TOPOISOMERASE POISONS, Biochimica et biophysica acta, N. Gene structure and expression, 1400(1-3), 1998, pp. 185-194
HUMAN DNA TOPOISOMERASE II-ALPHA-DEPENDENT DNA CLEAVAGE AND YEAST CELL-KILLING BY ANTHRACYCLINE ANALOGS
Authors: BINASCHI M FARINOSI R AUSTIN CA FISHER LM ZUNINO F CAPRANICO G
Citation: M. Binaschi et al., HUMAN DNA TOPOISOMERASE II-ALPHA-DEPENDENT DNA CLEAVAGE AND YEAST CELL-KILLING BY ANTHRACYCLINE ANALOGS, Cancer research, 58(9), 1998, pp. 1886-1892
A PROTEIN-MEDIATED MECHANISM FOR THE DNA SEQUENCE-SPECIFIC ACTION OF TOPOISOMERASE-II POISONS
Authors: CAPRANICO G BINASCHI M BORGNETTO ME ZUNINO F PALUMBO M
Citation: G. Capranico et al., A PROTEIN-MEDIATED MECHANISM FOR THE DNA SEQUENCE-SPECIFIC ACTION OF TOPOISOMERASE-II POISONS, Trends in pharmacological sciences, 18(9), 1997, pp. 323-329
RELATIONSHIP BETWEEN LETHAL EFFECTS AND TOPOISOMERASE II-MEDIATED DOUBLE-STRANDED DNA BREAKS PRODUCED BY ANTHRACYCLINES WITH DIFFERENT SEQUENCE SPECIFICITY
Authors: BINASCHI M CAPRANICO G DALBO L ZUNINO F
Citation: M. Binaschi et al., RELATIONSHIP BETWEEN LETHAL EFFECTS AND TOPOISOMERASE II-MEDIATED DOUBLE-STRANDED DNA BREAKS PRODUCED BY ANTHRACYCLINES WITH DIFFERENT SEQUENCE SPECIFICITY, Molecular pharmacology, 51(6), 1997, pp. 1053-1059
IRREVERSIBLE AND REVERSIBLE TOPOISOMERASE-II DNA CLEAVAGE STIMULATED BY CLEROCIDIN - SEQUENCE SPECIFICITY AND STRUCTURAL DRUG DETERMINANTS
Authors: BINASCHI M ZAGOTTO G PALUMBO M ZUNINO F FARINOSI R CAPRANICO G
Citation: M. Binaschi et al., IRREVERSIBLE AND REVERSIBLE TOPOISOMERASE-II DNA CLEAVAGE STIMULATED BY CLEROCIDIN - SEQUENCE SPECIFICITY AND STRUCTURAL DRUG DETERMINANTS, Cancer research, 57(9), 1997, pp. 1710-1716
MECHANISM OF ACTION OF DNA TOPOISOMERASE INHIBITORS
Authors: BINASCHI M ZUNINO F CAPRANICO G
Citation: M. Binaschi et al., MECHANISM OF ACTION OF DNA TOPOISOMERASE INHIBITORS, Stem cells, 13(4), 1995, pp. 369-379
MRP GENE OVEREXPRESSION IN A HUMAN DOXORUBICIN-RESISTANT SCLC CELL-LINE - ALTERATIONS IN CELLULAR PHARMACOKINETICS AND IN PATTERN OF CROSS-RESISTANCE
Authors: BINASCHI M SUPINO R GAMBETTA RA GIACCONE G PROSPERI E CAPRANICO G CATALDO I ZUNINO F
Citation: M. Binaschi et al., MRP GENE OVEREXPRESSION IN A HUMAN DOXORUBICIN-RESISTANT SCLC CELL-LINE - ALTERATIONS IN CELLULAR PHARMACOKINETICS AND IN PATTERN OF CROSS-RESISTANCE, International journal of cancer, 62(1), 1995, pp. 84-89
INFLUENCE OF STRUCTURAL MODIFICATIONS AT THE 3' AND 4' POSITIONS OF DOXORUBICIN ON THE DRUG ABILITY TO TRAP TOPOISOMERASE-II AND TO OVERCOME MULTIDRUG-RESISTANCE
Authors: CAPRANICO G SUPINO R BINASCHI M CAPOLONGO L GRANDI M SUARATO A ZUNINO F
Citation: G. Capranico et al., INFLUENCE OF STRUCTURAL MODIFICATIONS AT THE 3' AND 4' POSITIONS OF DOXORUBICIN ON THE DRUG ABILITY TO TRAP TOPOISOMERASE-II AND TO OVERCOME MULTIDRUG-RESISTANCE, Molecular pharmacology, 45(5), 1994, pp. 908-915
A STUDY OF CROSS-RESISTANCE PATTERN AND EXPRESSION OF MOLECULAR MARKERS OF MULTIDRUG-RESISTANCE IN A HUMAN SMALL-CELL LUNG-CANCER CELL-LINESELECTED WITH DOXORUBICIN
Authors: SUPINO R BINASCHI M CAPRANICO G GAMBETTA RA PROSPERI E SALA E ZUNINO F
Citation: R. Supino et al., A STUDY OF CROSS-RESISTANCE PATTERN AND EXPRESSION OF MOLECULAR MARKERS OF MULTIDRUG-RESISTANCE IN A HUMAN SMALL-CELL LUNG-CANCER CELL-LINESELECTED WITH DOXORUBICIN, International journal of cancer, 54(2), 1993, pp. 309-314
Risultati: 1-9 |